Clomipramine inhalation - Vectura

Drug Profile

Clomipramine inhalation - Vectura

Alternative Names: VR-776

Latest Information Update: 09 Sep 2011

Price : $50

At a glance

  • Originator Vectura
  • Class Dibenzazepines; Small molecules; Tricyclic antidepressants
  • Mechanism of Action Adrenergic uptake inhibitors; Dopamine modulators; Serotonin modulators; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Premature ejaculation

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 Jun 2007 Vectura completes a phase IIa trial in Premature ejaculation in the UK
  • 16 Nov 2005 Phase-I clinical trials in Premature ejaculation in United Kingdom (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top